Paraneoprastic opsoclonus-myoclonus syndrome - A review

Brain and Nerve

Volumn 62, Issue 4, 2010, Pages 365-369

  Matsumoto, Hideyuki ^a   Ugawa, Yoshikazu ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antineuronal antibody; Autoimmunity; Opsoclonus; Paraneoplastic syndrome; Pathophysiology

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BACLOFEN; CLONAZEPAM; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; NITRAZEPAM; PREDNISOLONE; PROPRANOLOL; RITUXIMAB; THIAMINE; TRAZODONE; MONOCLONAL ANTIBODY;

ANTIBODY DETECTION; BEHAVIOR DISORDER; BREAST CANCER; CEREBELLAR ATAXIA; ENCEPHALITIS; FASTIGIAL NUCLEUS; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; LUNG SMALL CELL CANCER; METABOLIC DISORDER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROBLASTOMA; OPSOCLONUS MYOCLONUS SYNDROME; OVARY CANCER; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW; SPEECH DISORDER; ADULT; CELLULAR IMMUNITY; CHILD; IMMUNOLOGY; PROGNOSIS;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CHILD; CYCLOPHOSPHAMIDE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; OPSOCLONUS-MYOCLONUS SYNDROME; PLASMA EXCHANGE; PROGNOSIS;

EID: 77951553400     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Wong A: An update on opsoclonus. Curr Opin Neurol 20: 25-31, 2007
2. Alabduljalil T, Behbehani R: Paraneoplastic syndromes in neuro-ophthalmology. Curr Opin Ophthalmol 18: 463-469, 2007
3. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327-340, 2008
4. Graus F, Dalmau J: Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol 20: 732-737, 2007
5. Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, et al: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004
6. Blaes F, Fühlhuber V, Korfei M, Tschernatsch M, Behnisch W, et al: Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome. Ann Neurol 58: 313-317, 2005
7. Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, et al: Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 53: 347-353, 2003
8. Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Moticka EJ, et al: B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology 62: 1526-1532, 2004
9. Pranzatelli MR, Tate ED, Travelstead AL, Barbosa J, Bergamini RA, et al: Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol 28: 585-593, 2006
10. van Toorn R, Rabie H, Warwick JM: Opsoclonus-myoclonus in an HIV-infected child on antiretroviral therapy - possible immune reconstitution inflammatory syndrome. Eur J Paediatr Neurol 9: 423-426, 2005
11. Korfei M, Fühlhuber V, Schmidt-Wöll T, Kaps M, Preissner KT, et al: Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome. J Neuroimmunol 170: 150-157, 2005
12. Zee DS, Robinson DA: A hypothetical explanation of saccadic oscillations. Ann Neurol 5: 405-414, 1979
13. Ellenberger C Jr, Campa JF, Netsky MG: Opsoclonus and parenchymatous degeneration of the cerebellum. The cerebellar origin of an abnormal ocular movement. Neurology 18: 1041-1046, 1968
14. Optican LM, Robinson DA: Cerebellar-dependent adaptive control of primate saccadic system. J Neurophysiol 44: 1058-1076, 1980
15. Ramat S, Leigh RJ, Zee DS, Optican LM: Ocular oscillations generated by coupling of brainstem excitatory and inhibitory saccadic burst neurons. Exp Brain Res 160: 89-106, 2005
16. Wong AM, Musallam S, Tomlinson RD, Shannon P, Sharpe JA: Opsoclonus in three dimensions: oculographic, neuropathologic and modelling correlates. J Neurol Sci 189: 71-81, 2001
17. Armstrong MB, Robertson PL, Castle VP: Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis. Pediatr Neurol 33: 365-367, 2005
18. Bataller L, Graus F, Saiz A, Vilchez JJ; Spanish Opsoclonus-Myoclonus Study Group: Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124: 437-443, 2001
19. Cher LM, Hochberg FH, Teruya J, Nitschke M, Valenzuela RF, et al: Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 75: 1678-1683, 1995
20. Mitchell WG, Brumm VL, Azen CG, Patterson KE, Aller SK, et al: Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia. Pediatrics 116: 901-907, 2005